Azifast 500 Tablet
Targets bacterial protein synthesis with tissue persistence that enables short-course treatment regimens for common infections.
Ipca Laboratories is an established Indian pharmaceutical manufacturer with a broad portfolio covering multiple therapeutic areas. The company focuses on the development and production of active pharmaceutical ingredients and finished dosage forms for both domestic and international markets. One of their formulations is currently listed on this platform, representing their specialty in various clinical sectors.
Targets bacterial protein synthesis with tissue persistence that enables short-course treatment regimens for common infections.
Ipca Laboratories operates as a significant manufacturer in the Indian pharmaceutical sector. The company maintains a presence in the development of varied generic medications, focusing on quality control and manufacturing processes that comply with international regulatory standards. By leveraging extensive research and development, the company provides a wide array of products that address diverse patient needs, ranging from acute therapy to chronic condition management.
The company is recognized for its vertical integration, producing both the raw chemical compounds and the final medications distributed to clinics and pharmacies. This internal capability allows for consistent supply chain management across their product range. Ipca Laboratories distributes its medications to numerous regions, maintaining a stable position within the competitive international pharmaceutical landscape.
The product range from Ipca Laboratories spans several therapeutic categories, including anti-infectives, cardiology, and pain management. These products are developed to meet the requirements of healthcare providers seeking reliable generic alternatives to branded medications. Their formulations often target broad-spectrum treatment needs, ensuring availability for patients requiring consistent pharmacological support.
As an example, products like Azifast 500 Tablet represent the manufacturer’s focus on infection control and antibiotic efficacy. The catalog reflects the company’s broader commitment to providing standardized dosage forms that adhere to established pharmaceutical protocols for concentration and stability.
These products are generic pharmaceutical formulations manufactured by Ipca Laboratories. Individual items in the catalog differ in active ingredient, formulation, strength, and clinical purpose. This page serves as a product catalog and does not constitute medical advice or an endorsement of any specific product. Readers should review the official product labeling and consult a healthcare professional for guidance on which medication suits their specific health requirements.